Copd symbicort 160 45 mcg is used long term to improve symptoms of chronic obstructive pulmonary disease copd including chronic bronchitis and emphysema for better breathing and fewer flare ups. Symbicort is an inhalation aerosol indicated for the treatment of copd and asthma the rise and chase phase 3 studies were devoted to testing the safety and efficacy of symbicort inhaler in adults with copd and children with asthma. Chronic obstructive pulmonary disease copd includes chronic bronchitis and emphysema people with copd have damaged inflamed or narrowed airways tubes in the lungs which makes breathing difficult the symptoms are breathlessness coughing and phlegm and can vary from mild to severe where day to day activities become limited. Symbicort budesonide and formoterol is a combination inhaler that has an inhaled corticosteroid and a long acting beta agonist long acting beta agonist is abbreviated laba symbicort is approved for the treatment of asthma for people ages 12 years and older as well as copd chronic obstructive pulmonary disease 1 it is made by astrazeneca. Symbicort 160 45 is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease copd including chronic bronchitis and or emphysema and to reduce copd exacerbations
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )